Complement-mediated serum activities against genetically defined capsular transformants of Haemophilus influenzae

Microbial Pathogenesis - Tập 10 - Trang 261-269 - 1991
Andrea J. Swift1, E.Richard Moxon2, Andre Zwahlen3, Jerry A. Winkelstein1
1Eudowood Division of Immunology, Department of Pediatrics, School of Medicine, The Johns Hopkins University, Baltimore, Maryland, U.S.A.
2Department of Paediatrics, Molecular Infectious Diseases Group, John Radcliffe Hospital, Headington, Oxford OX2 9DE, U.K.
3Hospital de Saint-Loup, Pompaples, Switzerland

Tài liệu tham khảo

Sell, 1973, Natural infections with Haemophilus influenzae in children. I. Types identified Winkelstein, 1982, Role of complement in the host's defense against Haemophilus influenzae Ross, 1984, Complement deficiency states and infection: epidemiology, pathogenesis and consequences of Neisserial and other infections in an immune deficiency, Medicine, 63, 243, 10.1097/00005792-198409000-00001 Crosson, 1976, Participation of complement in the nonimmune host's defense against experimental Haemophilus influenzae type b sepsis and meningitis, Infect Immun, 14, 882, 10.1128/IAI.14.4.882-887.1976 Corrall, 1982, Participation of complement in host defense against encapsulated Haemophilus influenzae, types a, c, and d, Infect Immun, 35, 759, 10.1128/IAI.35.3.759-763.1982 Zwahlen, 1983, Participation of complement in host defense against capsule-deficient Haemophilus influenzae, Infect Immun, 42, 708, 10.1128/IAI.42.2.708-715.1983 Zwahlen, 1989, The molecular basis of pathogenicity in Haemophilus influenzae: comparative virulence of genetically-related capsular transformants and correlation with changes in capsulation locus cap, Microbial Pathogenesis, 7, 225, 10.1016/0882-4010(89)90058-2 Anderson, 1972, Human serum activities against Haemophilus influenzae, type b, J Clin Invest, 51, 31, 10.1172/JCI106793 Branefors, 1980, Serum bactericidal effect on capsulated and non-capsulated Haemophilus influenzae, Acta Path Microbial Scand, 88, 47 Sutton, 1982, Differential complement resistance mediates virulence of Haemophilus influenzae type b, Infect Immun, 35, 95, 10.1128/IAI.35.1.95-104.1982 Crook, 1989, Opsonic requirements and interaction of Haemophilus influenzae with human polymorphonuclear neutrophil leukocytes studied by luminal-enhanced chemiluminescence, Microbial Pathogenesis, 7, 101, 10.1016/0882-4010(89)90029-6 Zwahlen, 1986, Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats, Microbial Pathogenesis, 1, 465, 10.1016/0882-4010(86)90008-2 Ely, 1986, Mutations affecting expression and maintenance of genes encoding the type b capsule of Haemophilus influenzae, J Bacteriol, 157, 44, 10.1128/jb.167.1.44-48.1986 Winkelstein, 1982, Genetically determined deficiency of the third component of complement in the dog: in vitro studies on the complement system and complement-mediated serum activities, J Immunol, 129, 2598, 10.4049/jimmunol.129.6.2598 Shin, 1971, The fifth component of guinea pig complement. II. Mechanism of SAC 1,4,2,3,5b formation, J Immunol, 106, 473, 10.4049/jimmunol.106.2.473 Shin, 1968, The third component of the guinea pig complement system. II. Kinetic study of reaction of EAC14,2a with C3, Biochemistry, 7, 2997, 10.1021/bi00848a041 Cates, 1985, Serum opsonic activity after immunization of adults with Haemophilus influenzae type b-diphtheria toxoid conjugate vaccine, Infect Immun, 48, 183, 10.1128/IAI.48.1.183-189.1985